BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 37224504)

  • 1. Glucocorticoid Receptors Drive Breast Cancer Cell Migration and Metabolic Reprogramming via PDK4.
    Dwyer AR; Perez Kerkvliet C; Truong TH; Hagen KM; Krutilina RI; Parke DN; Oakley RH; Liddle C; Cidlowski JA; Seagroves TN; Lange CA
    Endocrinology; 2023 Jun; 164(7):. PubMed ID: 37224504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucocorticoid receptors are required effectors of TGFβ1-induced p38 MAPK signaling to advanced cancer phenotypes in triple-negative breast cancer.
    Perez Kerkvliet C; Dwyer AR; Diep CH; Oakley RH; Liddle C; Cidlowski JA; Lange CA
    Breast Cancer Res; 2020 May; 22(1):39. PubMed ID: 32357907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stress sensing within the breast tumor microenvironment: how glucocorticoid receptors live in the moment.
    Kerkvliet CP; Truong TH; Ostrander JH; Lange CA
    Essays Biochem; 2021 Dec; 65(6):971-983. PubMed ID: 34132331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Taxol Induces Brk-dependent Prosurvival Phenotypes in TNBC Cells through an AhR/GR/HIF-driven Signaling Axis.
    Regan Anderson TM; Ma S; Perez Kerkvliet C; Peng Y; Helle TM; Krutilina RI; Raj GV; Cidlowski JA; Ostrander JH; Schwertfeger KL; Seagroves TN; Lange CA
    Mol Cancer Res; 2018 Nov; 16(11):1761-1772. PubMed ID: 29991529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast Tumor Kinase (Brk/PTK6) Is Induced by HIF, Glucocorticoid Receptor, and PELP1-Mediated Stress Signaling in Triple-Negative Breast Cancer.
    Regan Anderson TM; Ma SH; Raj GV; Cidlowski JA; Helle TM; Knutson TP; Krutilina RI; Seagroves TN; Lange CA
    Cancer Res; 2016 Mar; 76(6):1653-63. PubMed ID: 26825173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucocorticoid receptor antagonism as a novel therapy for triple-negative breast cancer.
    Skor MN; Wonder EL; Kocherginsky M; Goyal A; Hall BA; Cai Y; Conzen SD
    Clin Cancer Res; 2013 Nov; 19(22):6163-72. PubMed ID: 24016618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance of glucocorticoid signaling in triple-negative breast cancer patients: a newly revealed interaction with androgen signaling.
    Kanai A; McNamara KM; Iwabuchi E; Miki Y; Onodera Y; Guestini F; Khalid F; Sagara Y; Ohi Y; Rai Y; Yamaguchi R; Tanaka M; Miyashita M; Ishida T; Sasano H
    Breast Cancer Res Treat; 2020 Feb; 180(1):97-110. PubMed ID: 31989378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of SGK1 via glucocorticoid-influenced clinical outcome of triple-negative breast cancer patients.
    Zhang J; Miki Y; Iwabuchi E; Xu J; Kanai A; Sagara Y; Ohi Y; Rai Y; Yamaguchi R; Tanaka M; Ishida T; Suzuki T; Sasano H
    Breast Cancer Res Treat; 2023 Aug; 200(3):323-335. PubMed ID: 37286891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ligand-independent phosphorylation of the glucocorticoid receptor integrates cellular stress pathways with nuclear receptor signaling.
    Galliher-Beckley AJ; Williams JG; Cidlowski JA
    Mol Cell Biol; 2011 Dec; 31(23):4663-75. PubMed ID: 21930780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast Tumor Kinase (Brk/PTK6) Mediates Advanced Cancer Phenotypes via SH2-Domain Dependent Activation of RhoA and Aryl Hydrocarbon Receptor (AhR) Signaling.
    Dwyer AR; Kerkvliet CP; Krutilina RI; Playa HC; Parke DN; Thomas WA; Smeester BA; Moriarity BS; Seagroves TN; Lange CA
    Mol Cancer Res; 2021 Feb; 19(2):329-345. PubMed ID: 33172975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual-target MDM2/MDMX inhibitor increases the sensitization of doxorubicin and inhibits migration and invasion abilities of triple-negative breast cancer cells through activation of TAB1/TAK1/p38 MAPK pathway.
    Fan Y; Li M; Ma K; Hu Y; Jing J; Shi Y; Li E; Dong D
    Cancer Biol Ther; 2019; 20(5):617-632. PubMed ID: 30462562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucocorticoid receptor overexpression slightly shifts microRNA expression patterns in triple-negative breast cancer.
    Buschmann D; González R; Kirchner B; Mazzone C; Pfaffl MW; Schelling G; Steinlein O; Reithmair M
    Int J Oncol; 2018 Jun; 52(6):1765-1776. PubMed ID: 29620157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PRMT5 triggers glucocorticoid-induced cell migration in triple-negative breast cancer.
    Noureddine LM; Ablain J; Surmieliova-Garnès A; Jacquemetton J; Pham TH; Marangoni E; Schnitzler A; Bieche I; Badran B; Trédan O; Hussein N; Le Romancer M; Poulard C
    Life Sci Alliance; 2023 Oct; 6(10):. PubMed ID: 37536978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myeloid Zinc Finger 1 (MZF1) Maintains the Mesenchymal Phenotype by Down-regulating IGF1R/p38 MAPK/ERα Signaling Pathway in High-level MZF1-expressing TNBC cells.
    Yue CH; Liu JY; Chi CS; Hu CW; Tan KT; Huang FM; Pan YR; Lin KI; Lee CJ
    Anticancer Res; 2019 Aug; 39(8):4149-4164. PubMed ID: 31366500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The GR-PDK4 Axis of Evil: Hijacking a Stress SOS to Drive Metastasis.
    Chakraborty AA; Keri RA
    Endocrinology; 2023 Jun; 164(8):. PubMed ID: 37459450
    [No Abstract]   [Full Text] [Related]  

  • 16. Hsp90 Inhibition Results in Glucocorticoid Receptor Degradation in Association with Increased Sensitivity to Paclitaxel in Triple-Negative Breast Cancer.
    Agyeman AS; Jun WJ; Proia DA; Kim CR; Skor MN; Kocherginsky M; Conzen SD
    Horm Cancer; 2016 Apr; 7(2):114-26. PubMed ID: 26858237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nitro-fatty acid inhibition of triple-negative breast cancer cell viability, migration, invasion, and tumor growth.
    Woodcock CC; Huang Y; Woodcock SR; Salvatore SR; Singh B; Golin-Bisello F; Davidson NE; Neumann CA; Freeman BA; Wendell SG
    J Biol Chem; 2018 Jan; 293(4):1120-1137. PubMed ID: 29158255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential Glucocorticoid-Dependent Regulation and Function of the ERRFI1 Gene in Triple-Negative Breast Cancer.
    Mojica CAR; Ybañez WS; Olarte KCV; Poblete ABC; Bagamasbad PD
    Endocrinology; 2020 Jul; 161(7):. PubMed ID: 32432675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. STAT3 and GR Cooperate to Drive Gene Expression and Growth of Basal-Like Triple-Negative Breast Cancer.
    Conway ME; McDaniel JM; Graham JM; Guillen KP; Oliver PG; Parker SL; Yue P; Turkson J; Buchsbaum DJ; Welm BE; Myers RM; Varley KE
    Cancer Res; 2020 Oct; 80(20):4355-4370. PubMed ID: 32816914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cortisol-induced SRSF3 expression promotes GR splicing, RACK1 expression and breast cancer cells migration.
    Buoso E; Ronfani M; Galasso M; Ventura D; Corsini E; Racchi M
    Pharmacol Res; 2019 May; 143():17-26. PubMed ID: 30862604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.